BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32667139)

  • 41. The function of FUS in neurodevelopment revealed by the brain and spinal cord organoids.
    Zou H; Wang JY; Ma GM; Xu MM; Luo F; Zhang L; Wang WY
    Mol Cell Neurosci; 2022 Dec; 123():103771. PubMed ID: 36064132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of the prion-related Q/N domains in TDP-43 and FUS.
    Udan M; Baloh RH
    Prion; 2011; 5(1):1-5. PubMed ID: 21135580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
    Ishiguro A; Katayama A; Ishihama A
    FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage.
    Johnson MA; Deng Q; Taylor G; McEachin ZT; Chan AWS; Root J; Bassell GJ; Kukar T
    Neurobiol Dis; 2020 Dec; 146():105085. PubMed ID: 32950644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
    Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
    EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
    Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
    Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuron-to-Neuron Transfer of FUS in Drosophila Primary Neuronal Culture Is Enhanced by ALS-Associated Mutations.
    Feuillette S; Delarue M; Riou G; Gaffuri AL; Wu J; Lenkei Z; Boyer O; Frébourg T; Campion D; Lecourtois M
    J Mol Neurosci; 2017 May; 62(1):114-122. PubMed ID: 28429234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Prpar Mihevc S; Darovic S; Kovanda A; Bajc Česnik A; Župunski V; Rogelj B
    Brain; 2017 Jan; 140(1):13-26. PubMed ID: 27497493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
    Basu S; Rajendra KC; Alagar S; Bahadur RP
    Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
    Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
    Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations.
    Stoica R; Paillusson S; Gomez-Suaga P; Mitchell JC; Lau DH; Gray EH; Sancho RM; Vizcay-Barrena G; De Vos KJ; Shaw CE; Hanger DP; Noble W; Miller CC
    EMBO Rep; 2016 Sep; 17(9):1326-42. PubMed ID: 27418313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
    Wang T; Jiang X; Chen G; Xu J
    Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.
    Mitchell JC; McGoldrick P; Vance C; Hortobagyi T; Sreedharan J; Rogelj B; Tudor EL; Smith BN; Klasen C; Miller CC; Cooper JD; Greensmith L; Shaw CE
    Acta Neuropathol; 2013 Feb; 125(2):273-88. PubMed ID: 22961620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.
    Kobayashi Z; Tsuchiya K; Arai T; Aoki M; Hasegawa M; Ishizu H; Akiyama H; Mizusawa H
    J Neurol Sci; 2010 Jun; 293(1-2):6-11. PubMed ID: 20409561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Misregulated RNA processing in amyotrophic lateral sclerosis.
    Polymenidou M; Lagier-Tourenne C; Hutt KR; Bennett CF; Cleveland DW; Yeo GW
    Brain Res; 2012 Jun; 1462():3-15. PubMed ID: 22444279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The molecular pathology of frontotemporal lobar degeneration].
    Fujishiro H; Hasegawa M; Arai T
    Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration.
    Kawakami I; Kobayashi Z; Arai T; Yokota O; Nonaka T; Aoki N; Niizato K; Oshima K; Higashi S; Katsuse O; Hosokawa M; Hasegawa M; Akiyama H
    Acta Neuropathol Commun; 2016 Apr; 4():36. PubMed ID: 27044537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.